Stent: Use case
Use cases
Each use, its share of demand and volume, how critical the product is to it and why, and the price paid
| Use case | Volume | Unit | Criticality | Reason | Year | Source |
|---|---|---|---|---|---|---|
| Coronary stenting in India, 2016: 495,000 PCI procedures and an estimated 594,000 stents (Kaul, EuroIntervention 2017; an estimate) | 594,000 | stents (estimate) | Important | Balloon angioplasty and bypass surgery are other procedures for narrowed arteries [20], and stents were brought in to overcome the key limitations of balloon angioplasty [2], so the alternatives come with a penalty. | 2016 | [9][20][2] |
| Coronary stenting in India, 2015: 475,000 stents for 375,000 coronary interventions (ORF Table 1, the authors' estimates from National Intervention Council figures); a second estimate on a different basis | 475,000 | stents (estimate) | Important | Balloon angioplasty and bypass surgery are other procedures for narrowed arteries [20], and stents were brought in to overcome the key limitations of balloon angioplasty [2], so the alternatives come with a penalty. | 2015 | [10][20][2] |
as of 2026-11-13
Industries that buy it
The industries and kinds of firm that buy it, for which use case, and how critical it is to them
Used by- Hospitals and specialty hospital chains Placing stents in catheterisation laboratories · criticality important About 495,000 PCI procedures were carried out in India in 2016, with an estimated 594,000 stents used [9]; important because balloon angioplasty and bypass surgery exist but carry penalties [20][2].
as of 2026-11-13
How it is used
Lifetime, use per year and utilisation, by variant
| Measure | Value | Unit | Variant | Place | Year | Source |
|---|---|---|---|---|---|---|
| Stents used per PCI procedure (estimate) | 1.2 | stents per procedure | – | India | 2016 | [9] |
| Coronary drug-eluting stents implanted per million people, highest country value in the ESC Atlas table (France, table value) | 4805.2 | per million people | Drug-eluting | France | 2021 | [17] |
| Coronary drug-eluting stents implanted per million people, Germany (ESC Atlas table value) | 2787.5 | per million people | Drug-eluting | Germany | 2017 | [17] |
| Coronary drug-eluting stents implanted per million people, lowest country value in the ESC Atlas table (Armenia, table value) | 437.8 | per million people | Drug-eluting | Armenia | 2022 | [17] |
| Share of PCI procedures in which a stent was implanted (the review gives no place) | 80 | % (more than) | – | World | 1999 | [2] |
as of 2026-11-13
Prices
Unit prices by market or use, with year and source
| Market | Value | Unit | Year | Source |
|---|---|---|---|---|
| India, average retail price of a bare metal stent before the February 2017 cap | 45,000 | INR | 2017 | [9] |
| India, drug-eluting stent price before the cap, around INR 1.2 lakh (converted: 1.2 lakh is 120,000) | 120,000 | INR | 2017 | [10] |
| India, NPPA ceiling price of a bare metal stent, February 2017 | 7260 | INR | 2017 | [9][23] |
| India, NPPA ceiling price of a drug-eluting stent, February 2017 | 29,600 | INR | 2017 | [9][23] |
| India, NPPA revised ceiling price of a bare metal stent, notification of 12 February 2018 | 7660 | INR | 2018 | [11] |
| India, NPPA revised ceiling price of a drug-eluting stent, notification of 12 February 2018 | 27,890 | INR | 2018 | [11] |
| India, NPPA ceiling price of a bare metal stent with effect from 30 March 2022 (government table value) | 9373.03 | INR | 2022 | [24] |
| India, NPPA ceiling price of a drug-eluting stent, including bioresorbable scaffolds, with effect from 30 March 2022 (government table value) | 34,128.13 | INR | 2022 | [24] |
| India, ceiling price of a bare metal stent applicable in February 2026 | 10,692.69 | INR | 2026 | [25] |
| India, ceiling price of a drug-eluting stent applicable in February 2026 | 38,933.14 | INR | 2026 | [25] |
as of 2026-11-13
Sources
- State of the art: coronary artery stents – past, present and future EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
- The new pricing policy for coronary stents in India: a boon or a bane? EuroIntervention (Upendra Kaul), 2017, EuroIntervention 2017;13(3), published 20 June 2017, DOI 10.4244/EIJV13I3A40
- Price-cap is after all just a new price: The case of cardiac stents in India Observer Research Foundation (Ramesh Bhat and Denny John), 2017, Issue Brief, published 27 April 2017; Table 1, estimates compiled by the authors from National Intervention Council presentations and reports
- Lok Sabha Unstarred Question No. 2781, Guidelines by NPPA, answered 13 March 2018 Lok Sabha, Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), 2018
- SIPCP_CMDEST_1M_R,Coronary drug-eluting stents (per million people) European Society of Cardiology, ESC Atlas of Cardiology, table of country values, 2017 to 2023; indicator definition: total annual number of coronary metallic drug-eluting stents implanted
- Cardiovascular diseases (CVDs) World Health Organization (fact sheet), 2025, fact sheet of 31 July 2025
- Mission to provide Affordable, Quality Healthcare for All: Coronary Stent Prices capped, to bring down cost by about 380% Press Information Bureau, Government of India (Ministry of Chemicals and Fertilizers), 2017, posted 14 February 2017
- Affordable Medical Equipment to Patients Press Information Bureau, Government of India (Ministry of Chemicals and Fertilizers), 2022, posted 22 July 2022; ceiling price table with effect from 30 March 2022
- Increase in the Price of Cardiac Stents Press Information Bureau, Government of India (Ministry of Chemicals and Fertilizers), 2026, dated 13 February 2026